Spectroscopic optical cohernece tomography for intravascular imaging

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43HL092690-01
Agency Tracking Number: HL092690
Amount: $112,931.00
Phase: Phase I
Program: SBIR
Awards Year: 2008
Solicitation Year: 2008
Solicitation Topic Code: N/A
Solicitation Number: PHS2007-2
Small Business Information
SOUTHWEST SCIENCES, INC.
SOUTHWEST SCIENCES, INC., 1570 PACHECO ST, STE E-11, SANTA FE, NM, 87505
DUNS: 153579891
HUBZone Owned: Y
Woman Owned: Y
Socially and Economically Disadvantaged: Y
Principal Investigator
 KRISTEN PETERSON
 (505) 984-1322
 PETERSON@SWSCIENCES.COM
Business Contact
Phone: (505) 984-1322
Email: astanton@swsciences.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The overall objective of this SBIR project is the development of a rapid, high resolution optical method for in vivo imaging with a specific emphasis on intravascular imaging and the identification of vulnerable plaque. The approach uses a novel harmonic detection method for optical coherence tomography (OCT) that will allow depth resolved near infrared spectroscopy in conjunction with structural imaging. Since different structures in atherosclerotic plaques, such as the fibrotic caps, lipid pools and calcifications have different near infrared spectroscopic features, spectroscopic OCT is a promising approach to enhancing contrast in optical coherence tomography. Southwest Sciences recently developed a harmonic detect ion method for optical coherence tomography for the removal of artifacts inherent to Fourier domain OCT, but the method can also be used to provide the phase information necessary for spectroscopic OCT. Harmonic detection is easily applied because it uses a simple sine- wave modulation of the interferometer, with detection at harmonics of the applied wave. Phase I of this project focuses on demonstrating spectroscopic OCT using our harmonic detection technology. In particular, a near infrared absorption feature of lipid, which is an important component of vulnerable atherosclerotic plaques, will be used to demonstrate contrast enhancement resulting from spectroscopic OCT. In Phase II, we will proceed with design and construction of a fiber-optic, cathete r probe instrument for intra-luminal imaging of arteries, with the goal of conducting Phase III clinical studies.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government